688338.SH
赛科希德
SSE · Healthcare · Medical - Devices · CN
CNY 30.66
−2.97%Year over year
Reported trailing growth
- Revenue
- -14.7%
- EBITDA
- —
- EBIT
- -18.4%
- EPS
- -17.5%
- Free cash flow
- -7.7%
- Operating cash flow
- -12.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +4.8%
- EBITDA
- -1.5%
- EBIT
- -4.2%
- Net income
- -4.9%
- EPS
- -4.6%
- Free cash flow
- +140.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026